Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary AtresiaBenjamin L. Shneider, Emily Elgert, John C. Magee et al.|The Journal of Pediatrics|2015Cited by 146
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trialJane C. Burns, Nichole Samuy, Kavita Sharma et al.|The Lancet Child & Adolescent Health|2021Cited by 113
Temporal clustering of Kawasaki disease cases around the worldJennifer Burney, Hiroyuki Suzuki, Laurel L. DeHaan et al.|Scientific Reports|2021Cited by 17
Association of Acute Anti-inflammatory Treatment With Medium-term Outcomes for Coronary Artery Aneurysms in Kawasaki DiseaseKevin G. Friedman, Claudia Renaud, Brian W. McCrindle et al.|CJC Pediatric and Congenital Heart Disease|2022Cited by 1